• Trials for Mild Cognitive Impairment, Inflammatory Bowel Disease, MS; New ePRO Offering; THREAD Acquires InVibe

    Clinical Research News | Trials are in line for treating mild cognitive impairment, inflammatory bowel disease, and MS; ObvioHealth announces a new ePRO offering; positive results for Renalytix risk monitoring tool in diabetic kidney disease study; acquisitions, mergers, and more.

    Feb 2, 2022

  • Overcoming The Challenges of Outsourcing Rare Disease Trials

    Clinical Research News | Anyone who has ever played the game of telephone as a child knows only too well how a message can become completely scrambled by the time it passes through a succession of people. A similar type of communication breakdown can happen when a protocol gets communicated by a study sponsor to a contract research organization (CRO), and then handed off to study managers or monitors and ultimately clinical trial sites, especially for rare disease trials.

    Jan 31, 2022